Reflexiones sobre el uso de warfarina en las afecciones cardiacas

Authors

  • Oscar Liza Hernández Hospital Dr. Octavio de la Concepción y la Pedraja. Universidad de Ciencias Médicas de Camaguey

Downloads

Download data is not yet available.

Author Biography

Oscar Liza Hernández, Hospital Dr. Octavio de la Concepción y la Pedraja. Universidad de Ciencias Médicas de Camaguey

Especialista de Primer grado en Medicina General integral  y de segundo grado en Medicina Intensiva y Emergencias

References

1.Guevara Gonzales LA, Chil Díaz R. Tratamiento antitrombótico en la enfermedad cardiovascular. En: Guevara Gonzales LA, Chil Díaz R, editores. Cirugía Cardiovascular. La Habana: Editorial Científico-Técnica; 2009. p. 307-16.

2.Rodríguez Reyes H, Arauz Góngora A, Asensio Lafuente E, Celaya Cota M de J, Cordero-Cabra A, Guevara Valdivia M, et al. Reunión multidisciplinaria sobre el uso de los anticoagulantes orales directos en la fibrilación auricular no valvular. Arch Cardiol Mex [Internet]. Abr-Jun 2017 [citado 12 Jul 2017];87(2):[aprox. 12 p.]. Disponible en: http://www.elsevier.es/es-revista-archivos-cardiologia-mexico-293-articulo-reunion-multidisciplinaria-sobre-el-uso-S1405994016300660

3.Jeffrey IW. Hemostasia, trombosis, fibrinóliticos y enfermedad cardiovascular. En: Braundwald E, editor. Tratado de Cardiología Texto de Medicina Cardiovascular. Barcelona: España: Elsevier; 2013. p. 1868-92.

4.Camm AJ, Kirchof P, Lip GY. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;19:2349-429.

5.Cope S, Clemens A, Hammès F, Noack H, Jansen JP. Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials. Value Health. 2015 Mar;18(2):234–49.

6.Andreu JM, Roldán V, García Navarro M, Ruipérez JÁ, Valdés M, Marín F. ¿Debe añadirse terapia antiagregante plaquetaria a la anticoagulación oral en los pacientes con fibrilación auricular y enfermedad vascular? Revisión de la evidencia disponible. Arch Cardiol Mex. 2012;82(3):248-51.

Downloads

Published

2017-09-29

How to Cite

1.
Liza Hernández O. Reflexiones sobre el uso de warfarina en las afecciones cardiacas. Arch méd Camagüey [Internet]. 2017 Sep. 29 [cited 2025 Dec. 24];21(5):571-3. Available from: https://revistaamc.sld.cu/index.php/amc/article/view/5244

Issue

Vol. 21 No. 5 (2017)

Section

Letter to the editor

License

Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.

Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.

(Download Statement of potential conflicts of interest)

The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).

This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/